IDH1 and glioblastoma: Based on differential genes, our findings revealed that 31 nrlncRNAs impacted the survival of IDH-wild-type GBM patients, and 6 of them (RP11-131L12.4, RP11-419117.1, PCBP3-OT1, AC002116.7, RP11-29P20.1, and RP11-325L12.7) were chosen to create the prognostic signature.